Trial NCT03411473

View at ClinicalTrials.gov 
Org. Study IDs: C-500-03

Last trial update was posted on 2020-06-02

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

NSCLC Stage IV

Stopping Reasons

Trial will not proceed due to changes in the treatment landscape.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID